[go: up one dir, main page]

EE200000796A - Pharmaceutical pellets, method of manufacture and pharmaceutical dosage form, use of pellets for the preparation of a pharmaceutical dosage form, and pharmaceutical packaging - Google Patents

Pharmaceutical pellets, method of manufacture and pharmaceutical dosage form, use of pellets for the preparation of a pharmaceutical dosage form, and pharmaceutical packaging

Info

Publication number
EE200000796A
EE200000796A EEP200000796A EEP200000796A EE200000796A EE 200000796 A EE200000796 A EE 200000796A EE P200000796 A EEP200000796 A EE P200000796A EE P200000796 A EEP200000796 A EE P200000796A EE 200000796 A EE200000796 A EE 200000796A
Authority
EE
Estonia
Prior art keywords
pharmaceutical
pellets
dosage form
pharmaceutical dosage
manufacture
Prior art date
Application number
EEP200000796A
Other languages
Estonian (et)
Inventor
Florent Victor De Cond Valentin
Marie Victor Gilis Paul
Putteman Peter
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200000796A publication Critical patent/EE200000796A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200000796A 1998-04-27 1999-04-20 Pharmaceutical pellets, method of manufacture and pharmaceutical dosage form, use of pellets for the preparation of a pharmaceutical dosage form, and pharmaceutical packaging EE200000796A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201331 1998-04-27
PCT/EP1999/002768 WO1999055313A1 (en) 1998-04-27 1999-04-20 Pellets having a core coated with a lipid lowering agent and a polymer

Publications (1)

Publication Number Publication Date
EE200000796A true EE200000796A (en) 2002-06-17

Family

ID=8233644

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000796A EE200000796A (en) 1998-04-27 1999-04-20 Pharmaceutical pellets, method of manufacture and pharmaceutical dosage form, use of pellets for the preparation of a pharmaceutical dosage form, and pharmaceutical packaging

Country Status (14)

Country Link
EP (1) EP1073424A1 (en)
JP (1) JP2002544118A (en)
KR (1) KR20010041460A (en)
CN (1) CN1308523A (en)
AU (1) AU3710099A (en)
BG (1) BG104757A (en)
BR (1) BR9909963A (en)
CA (1) CA2328970A1 (en)
EE (1) EE200000796A (en)
HU (1) HUP0102052A3 (en)
NO (1) NO20005426D0 (en)
PL (1) PL358909A1 (en)
SK (1) SK15252000A3 (en)
WO (1) WO1999055313A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
DE60209673T2 (en) * 2002-10-22 2006-09-21 Rohm And Haas Co. tablet coating
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
EP1708680A2 (en) * 2004-01-21 2006-10-11 Janssen Pharmaceutica N.V. Mitratapide oral solution
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
FR2897267A1 (en) * 2006-02-16 2007-08-17 Flamel Technologies Sa MULTIMICROPARTICULAR PHARMACEUTICAL FORMS FOR PER OS ADMINISTRATION
CN112074505B (en) 2018-03-08 2024-04-05 因赛特公司 Aminopyrazine diol compounds as PI 3K-gamma inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ295353A (en) * 1994-10-27 1998-08-26 Janssen Pharmaceutica Nv Heterocyclyl-thiomethyl substituted dioxolane derivatives and medicaments compositions thereof

Also Published As

Publication number Publication date
CA2328970A1 (en) 1999-11-04
AU3710099A (en) 1999-11-16
KR20010041460A (en) 2001-05-25
NO20005426L (en) 2000-10-27
WO1999055313A1 (en) 1999-11-04
BG104757A (en) 2001-05-31
EP1073424A1 (en) 2001-02-07
NO20005426D0 (en) 2000-10-27
JP2002544118A (en) 2002-12-24
CN1308523A (en) 2001-08-15
BR9909963A (en) 2000-12-26
HUP0102052A2 (en) 2002-05-29
HUP0102052A3 (en) 2002-10-28
PL358909A1 (en) 2004-08-23
SK15252000A3 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
PL396568A1 (en) Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
EE9900453A (en) Granule, pharmaceutical dosage form, method of preparation of the granules and drug-coated granules
EE9700043A (en) Substituted oxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE9700031A (en) Pyrido-linked thienyl and furanyloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE04464B1 (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
EE9700145A (en) Cycloalkanepyridines, their method of preparation, their use in the manufacture of medicinal products and medicinal products containing these compounds
EE9700060A (en) 2-Aryl-substituted pyridines, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE04417B1 (en) Oral pharmaceutical pulsatile dosage form, method of preparation and use
EE9700044A (en) Heteroaryloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds.
EE200000468A (en) The compounds, their use and the pharmaceutical composition
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
NO20003218L (en) Oral pharmaceutical dosage form with prolonged release effect
EE200100319A (en) Controlled release galantamine preparation, method of preparation, dosage form and pharmaceutical packaging
EE200100375A (en) Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicament
EE04739B1 (en) Thienylazolylalkoxyethanamine derivatives, process and their preparation, pharmaceutical composition and intermediate, and process for the preparation thereof
EE200100314A (en) A method of making a pharmaceutical composition, a pharmaceutical composition and its use
EE200000651A (en) Azoles, process for their preparation, use and pharmaceutical composition
EE200000226A (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
HUP0102599A3 (en) Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
DE69934781D1 (en) MORPHINSULFATE-CONTAINING MICROGRANULATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
EE200100615A (en) A microgranule, a process for its preparation and a pharmaceutical preparation
EE200000796A (en) Pharmaceutical pellets, method of manufacture and pharmaceutical dosage form, use of pellets for the preparation of a pharmaceutical dosage form, and pharmaceutical packaging
EE04914B1 (en) Eletriptan Hydrobromide Monohydrate, Its Use and Process for its Preparation, and Pharmaceutical Composition Containing Eletriptan Hydrobromide Monohydrate
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use